[go: up one dir, main page]

CN105267925A - Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine - Google Patents

Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine Download PDF

Info

Publication number
CN105267925A
CN105267925A CN201510789534.1A CN201510789534A CN105267925A CN 105267925 A CN105267925 A CN 105267925A CN 201510789534 A CN201510789534 A CN 201510789534A CN 105267925 A CN105267925 A CN 105267925A
Authority
CN
China
Prior art keywords
medicine
radix
blood
puerperal
pelvic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510789534.1A
Other languages
Chinese (zh)
Inventor
王倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510789534.1A priority Critical patent/CN105267925A/en
Publication of CN105267925A publication Critical patent/CN105267925A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of gynecological and obstetrical medicines, and particularly relates to a medicine for treating postpartum pelvic blood stagnation and a method for preparing the medicine. The medicine for treating the postpartum pelvic blood stagnation comprises angelica sinensis, ligusticum wallichii, peach seeds, herba leonuri, roasted ginger, prepared licorice, root-bark of peony trees, charred schizonepeta, frankincense, hawthorn, cattail pollen, trogopterus dung, rhizoma corydalis, radix ophiopogonis, schisandra chinensis, fried medicated leaven, fructus amomi, cinnamon, astragalus, white peony roots and prepared radix rehmanniae. The medicine and the method have the advantages that effects of removing blood stagnation, specially nourishing new blood, nourishing blood, regulating qi, tonifying patients during promotion and nourishing the blood during removal can be realized by the medicine which is a medicine composition, the medicine is an effective postpartum medicine in good prescription, and excellent treatment effects can be realized for postpartum uterine contraction heat and poor uterine regression besides the pelvic blood stagnation; the medicine is not a medicine for relieving pain, action mechanisms of the medicine include eliminating the blood stagnation, nourishing the new blood and dispersing lump in the nourished blood, the pain due to the pelvic blood stagnation cannot be treated by the medicine, but abdominal pain due to the pelvic blood stagnation can be treated in new blood nourishing procedures.

Description

A kind of medicine and preparation method for the treatment of pelvic venous stasis in puerperal
Technical field
The invention belongs to department of obstetrics and gynecology drug world, be specifically related to a kind of medicine for the treatment of pelvic venous stasis in puerperal, also relate to the preparation method of above-mentioned medicine.
Background technology
Puerperal, pelvic cavity Blood stasis was clinical common disease, its clinical manifestation is, women's clot in puerperal is more than, lochia, or row and not smooth, stomachache is more than, serious even forms one piece, press what for pain, women is mainly with for being the pain that prolonged lochia or retention of lochia cause, be actually because pelvic congestion does not scatter, knot makes agglomerating and pain that is that cause.This disease is mainly in healthy and strong married woman, it is the performance that blood is had a surplus, not insufficiency of blood, if adopt the medicine of removing blood stasis, although can blood stasis be removed, but can exhaust puerpera's vital essence unavoidably, according to the Therapeutic Principle of Chinese medicine " blood stasis does not go, fresh blood do not give birth to ", the clinical practice Eradicates stasis of blood that confirms only to invigorate blood circulation just can reach the raw object of blood stasis, fresh blood.
Therefore, need to suit the remedy to the case for above-mentioned symptom, invent a kind of not loss women vigour and pelvic venous stasis is had to the Chinese medicine of obvious therapeutic effect.
Summary of the invention
In order to solve above-mentioned technical problem, the invention provides a kind of medicine effectively treating women's pelvic venous stasis in puerperal, the stomachache that pelvic congestion causes do not specialized in by above-mentioned medicine, but in treatment blood stasis process, repercussive blood, tissue regeneration promoting blood, eliminating stagnation block, eliminates stomachache;
Present invention also offers the preparation method of said medicine.
Treat a medicine for pelvic venous stasis in puerperal, this medicine comprises the raw material of following portions by weight:
Radix Angelicae Sinensis 20-30 Rhizoma Chuanxiong 5-15 Semen Persicae 2-9
Herba Leonuri 3-9 black Rhizoma Zingiberis Recens 1-6 Radix Glycyrrhizae Preparata 1-4
Cortex Moutan 2-8 black Herba Schizonepetae 1-5 Olibanum 1-6
Fructus Crataegi 1-5 Pollen Typhae 1-5 Oletum Trogopterori 2-8
Rhizoma Corydalis 1-5 1-6 Radix Ophiopogonis Fructus Schisandrae Chinensis 3-8
Massa Medicata Fermentata (parched to brown) 1-4 Fructus Amomi 2-10 Cortex Cinnamomi 1-6
Radix Astragali 3-12 Radix Paeoniae Alba 2-10 Radix Rehmanniae Preparata 1-9.
Preferably, above-mentioned medicine comprises the raw material of following portions by weight:
Radix Angelicae Sinensis 22-28 Rhizoma Chuanxiong 5-15 Semen Persicae 2-8
Herba Leonuri 3-9 black Rhizoma Zingiberis Recens 1-6 Radix Glycyrrhizae Preparata 1-4
Cortex Moutan 3-7 black Herba Schizonepetae 1-5 Olibanum 1-6
Fructus Crataegi 1-5 Pollen Typhae 1-4 Oletum Trogopterori 2-7
Rhizoma Corydalis 1-5 1-5 Radix Ophiopogonis Fructus Schisandrae Chinensis 3-7
Massa Medicata Fermentata (parched to brown) 1-4 Fructus Amomi 2-9 Cortex Cinnamomi 1-6
Radix Astragali 3-12 Radix Paeoniae Alba 2-9 Radix Rehmanniae Preparata 1-8.
Preferred, above-mentioned medicine comprises the raw material of following portions by weight:
Radix Angelicae Sinensis 25 Rhizoma Chuanxiong 10 Semen Persicae 6
Herba Leonuri 5 black Rhizoma Zingiberis Recens 3 Radix Glycyrrhizae Preparata 2
Cortex Moutan 5 black Herba Schizonepetae 3 Olibanum 3
Fructus Crataegi 2 Pollen Typhae 3 Oletum Trogopterori 5
Rhizoma Corydalis 3 Fructus Schisandrae Chinensis Radix Ophiopogonis 46
Massa Medicata Fermentata (parched to brown) 2 Fructus Amomi 6 Cortex Cinnamomi 3
The Radix Astragali 8 Radix Paeoniae Alba 7 Radix Rehmanniae Preparata 6.
The preparation method of the medicine of above-mentioned treatment pelvic venous stasis in puerperal, comprises following step:
(1) get above-mentioned preferred parts by weight and get each raw material, put into 300-500 part water and soak 20-40min;
(2) boiled for the medicine intense fire in step (1) rear slow fire is stewed 10-20min slowly, then add 20-50 part yellow wine, continue to decoct 8-15min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use;
(3) in the filtering residue of step (2), add 200-400 part water, the boiled rear slow fire of intense fire stewes 10-20min slowly, then adds 20-50 part yellow wine, continues to decoct 8-15min, Guan Huo, pours out medicinal liquid;
(4) get the medicinal liquid obtained in step (1) and (2), combine, add brown sugar 5-10 part, Stigma Croci 0.001-0.003 part, stirs, and must treat the medicine of pelvic venous stasis in puerperal.
Preferably, in above-mentioned step (1), put into 400 parts of water and soak half an hour.
In above-mentioned step (2), boiled for the medicine intense fire in step (1) rear slow fire is stewed 15min slowly, then adds 40 parts of yellow wine, continue to decoct 12min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use.
In above-mentioned step (3), add 300 parts of water in the filtering residue of step (2), the boiled rear slow fire of intense fire stewes 15min slowly, then adds 40 parts of yellow wine, continues to decoct 12min, Guan Huo, pours out medicinal liquid.
Above-mentioned brown sugar is 8 parts.
Above-mentioned Stigma Croci 0.002 part.
Pharmaceutical composition of the present invention, Eradicates is except blood stasis, and special tissue regeneration promoting blood, hemopoietic is regulated the flow of vital energy, and have benefit in row, having life in change, is good recipe panacea in puerperal, and except treatment pelvic venous stasis, for postpartum uterine contraction heat, uterus involution is bad also good therapeutic effect.Above-mentioned medicine is not the medicine bitterly that relieves the pain, and its mechanism of action is Eradicates blood stasis, and tissue regeneration promoting blood disappears block within hemopoietic, does not treat the pain that pelvic congestion causes, but in the process of tissue regeneration promoting blood, has but treated the colic symptoms that pelvic congestion causes.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described, so that those skilled in the art more understands the present invention, but does not therefore limit the present invention.
Embodiment 1
The preparation method of the medicine for the treatment of pelvic venous stasis in puerperal, comprises following step:
(1) get each raw material by following parts by weight, put into 400 parts of water and soak half an hour;
Radix Angelicae Sinensis 25 Rhizoma Chuanxiong 10 Semen Persicae 6
Herba Leonuri 5 black Rhizoma Zingiberis Recens 3 Radix Glycyrrhizae Preparata 2
Cortex Moutan 5 black Herba Schizonepetae 3 Olibanum 3
Fructus Crataegi 2 Pollen Typhae 3 Oletum Trogopterori 5
Rhizoma Corydalis 3 Fructus Schisandrae Chinensis Radix Ophiopogonis 46
Massa Medicata Fermentata (parched to brown) 2 Fructus Amomi 6 Cortex Cinnamomi 3
The Radix Astragali 8 Radix Paeoniae Alba 7 Radix Rehmanniae Preparata 6;
(2) boiled for the medicine intense fire in step (1) rear slow fire is stewed 15min slowly, then add 40 parts of yellow wine, continue to decoct 12min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use;
(3) in the filtering residue of step (2), add 300 parts of water, the boiled rear slow fire of intense fire stewes 15min slowly, then adds 40 parts of yellow wine, continues to decoct 12min, Guan Huo, pours out medicinal liquid;
(4) get the medicinal liquid obtained in step (1) and (2), combine, add 8 parts, brown sugar, Stigma Croci 0.002 part, stirs, and must treat the medicine of pelvic venous stasis in puerperal.
For the curative effect of women's blood stasis disease, lysophosphatidic acid (LPA) in general investigation serum, LPA in serum is mainly subject to activated by thrombin by the platelet in coagulation process and discharges human blood, it is the weight molecules product in blood coagulation and thrombosis, LPA content in blood reflects the development of syndrome of blood stasis to a certain extent and lapses to, and much research also shows LPA and coagulation process is closely related.
The present invention studies with rat experiment the impact that LPA is subject to said medicine.
Concrete experimental procedure is as follows:
Select healthy female sd inbred rats 70, male SD rat 30, Mus is about 10 months age, and its average weight is 220 ± 20 grams;
Experimental agents:
The medicine of A embodiment 1;
Step B gets each raw material by following parts by weight in (1), puts into 400 parts of water and soaks half an hour;
Radix Angelicae Sinensis 25 Rhizoma Chuanxiong 10 Semen Persicae 6
Herba Leonuri 5 black Rhizoma Zingiberis Recens 3 Radix Glycyrrhizae Preparata 2
Cortex Moutan 5 black Herba Schizonepetae 3 Olibanum 3
Oletum Trogopterori 5 Radix Paeoniae Alba 7 Radix Rehmanniae Preparata 6
Rhizoma Corydalis 3 Fructus Schisandrae Chinensis Radix Ophiopogonis 46
Massa Medicata Fermentata (parched to brown) 2 Fructus Amomi 6 Cortex Cinnamomi 3
The Radix Astragali 8;
Compared with embodiment 1, eliminate two taste medicines: Fructus Crataegi, Pollen Typhae; All the other are identical;
C is relative to embodiment 1, and dosage reduces to 3/4;
Following adopted mifepristone sheet is manufactured by Zizhu Pharmaceutical Co., Ltd., Beijing;
Misoprostol tablets by LC-MS is manufactured by Zizhu Pharmaceutical Co., Ltd., Beijing;
Method
Leave and take 10 female rats at random as a control group;
All the other rat adaptabilities raise after female Mus and malely to mate with 2:1, carry out vaginal suppository and vaginal smear microscopy morning next day, to find that the same day of vaginal suppository and sperm was for pregnant 1st day, in gestation the 7th day difference gavage mifepristone sheet (8.3mg/kg, 8:00) with misoprostol (0.1mg/kg, by the change of hemorheology index of correlation, 18:00) duplicating model, judges puerperal, whether blood stasis model copied successfully.
The successful rat of Selection Model 60, is divided into 4 groups (i.e. model group, A, B, C tri-groups) at random, often organizes 15, free diet, adopts gavage (10ml/kg), every day twice, continuous 7 days;
Observation index
Last administration is after 1 hour, by whole rat 35g/L chloral hydrate (10ml/kg) intraperitoneal injection of anesthesia, cut abdominal cavity and expose ventral aorta, puncture abdominal aortic blood anticoagulant, get anticoagulation to detect for hemorheology index, stay the centrifugal rear taking-up supernatant blood plasma of appropriate anticoagulation frozen to be measured;
Indexs measure: adopt rotary blood flow graph to survey blood viscosity index, comprise whole blood low shear rate viscosity (5s -1), shear rate viscosity (30s in whole blood -1), whole blood height shear rate viscosity (200s -1), Plasma Viscosity.Adopt enzyme-linked immunosorbent assay (ELISA) reagent box (Yuan Ye bio tech ltd, Shanghai), detect rat blood serum LPA by ELX-800 microplate reader.
Each group of rat LPA comparision contents, the horizontal compared with normal matched group of model group rats LPA obviously increases, and compares with model group, and A group LPA level significantly reduces.
Testing result is as follows:
Each group of rat blood serum LPA comparision contents
Result of study shows, the medicine of the present embodiment can reduce rat whole blood viscosity and Plasma Viscosity in puerperal to a certain extent, points out medicine of the present invention effective for the treatment for the treatment of postnatal blood stasis disease.In serum, LPA is mainly subject to activated by thrombin by the platelet in coagulation process and discharges, and be the important molecule product in blood coagulation and thrombosis, the relation of LPA and Blood stasis have also been obtained the support of many results of study.
Clinical experiment
King so-and-so, 15 days puerperal, stomachache, anus acid is risen tenesmus, is attended by lumbago, has clot in lochia; Ultrasound diagnosis, finds there is blood stasis in pelvic cavity.
Pelvic congestion belongs to angiopathy more complicated in department of obstetrics and gynecology, the same pelvic inflammatory disease of clinical symptoms, the gynaecopathias such as adnexitis, its principal patient is the women having childbearing history or miscarriage, induced labor history, general employing colorful Doppler ultrasound diagnostic apparatus, adopt frequency be 3.5MHz can detect whether have pelvic congestion through abdomen convex array probe.
Detect through above-mentioned B ultrasonic, find that so-and-so vein of king is gathered into similar round or cellular agglomerate, uterus congestion enlargement, myometrium venectasia; Doctor judges, so-and-so ill disease of king is pelvic venous stasis;
Adopt Drug therapy of the present invention, potion is taken at twice, and every day, sooner or later respectively once after three days, stomachache disappeared, and the mental status is clearly better, and muscle power increases; After five days, malaise symptoms disappears; Ultrasound diagnosis again, finds that pelvic cavity has recovered normal, without blood stasis symptom.
Embodiment 2
The preparation method of the medicine for the treatment of pelvic venous stasis in puerperal, comprises following step:
(1) get each raw material by following parts by weight, put into 300 parts of water and soak 20min;
Radix Angelicae Sinensis 20 Rhizoma Chuanxiong 5 Semen Persicae 2
Herba Leonuri 3 black Rhizoma Zingiberis Recens 1 Radix Glycyrrhizae Preparata 1
Cortex Moutan 2 black Herba Schizonepetae 1 Olibanum 1
Fructus Crataegi 1 Pollen Typhae 1 Oletum Trogopterori 2
Rhizoma Corydalis 1 Fructus Schisandrae Chinensis Radix Ophiopogonis 13
Massa Medicata Fermentata (parched to brown) 1 Fructus Amomi 2 Cortex Cinnamomi 1
The Radix Astragali 3 Radix Paeoniae Alba 2 Radix Rehmanniae Preparata 1;
(2) boiled for the medicine intense fire in step (1) rear slow fire is stewed 10min slowly, then add 20 parts of yellow wine, continue to decoct 8min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use;
(3) in the filtering residue of step (2), add 200 parts of water, the boiled rear slow fire of intense fire stewes 10min slowly, then adds 20 parts of yellow wine, continues to decoct 8min, Guan Huo, pours out medicinal liquid;
(4) get the medicinal liquid obtained in step (1) and (2), combine, add 5 parts, brown sugar, Stigma Croci 0.001 part, stirs, and must treat the medicine of pelvic venous stasis in puerperal.
Embodiment 3
The preparation method of the medicine for the treatment of pelvic venous stasis in puerperal, comprises following step:
(1) get each raw material by following parts by weight, put into 500 parts of water and soak 40min;
Radix Angelicae Sinensis 30 Rhizoma Chuanxiong 15 Semen Persicae 9
Herba Leonuri 9 black Rhizoma Zingiberis Recens 6 Radix Glycyrrhizae Preparata 4
Cortex Moutan 8 black Herba Schizonepetae 5 Olibanum 6
Fructus Crataegi 5 Pollen Typhae 5 Oletum Trogopterori 8
Rhizoma Corydalis 5 Fructus Schisandrae Chinensis Radix Ophiopogonis 68
Massa Medicata Fermentata (parched to brown) 4 Fructus Amomi 10 Cortex Cinnamomi 6
The Radix Astragali 12 Radix Paeoniae Alba 10 Radix Rehmanniae Preparata 9;
(2) boiled for the medicine intense fire in step (1) rear slow fire is stewed 20min slowly, then add 50 parts of yellow wine, continue to decoct 15min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use;
(3) in the filtering residue of step (2), add 400 parts of water, the boiled rear slow fire of intense fire stewes 20min slowly, then adds 50 parts of yellow wine, continues to decoct 15min, Guan Huo, pours out medicinal liquid;
(4) get the medicinal liquid obtained in step (1) and (2), combine, add 10 parts, brown sugar, Stigma Croci 0.003 part, stirs, and must treat the medicine of pelvic venous stasis in puerperal.

Claims (9)

1. treat a medicine for pelvic venous stasis in puerperal, it is characterized in that, described medicine comprises the raw material of following portions by weight:
Radix Angelicae Sinensis 20-30 Rhizoma Chuanxiong 5-15 Semen Persicae 2-9
Herba Leonuri 3-9 black Rhizoma Zingiberis Recens 1-6 Radix Glycyrrhizae Preparata 1-4
Cortex Moutan 2-8 black Herba Schizonepetae 1-5 Olibanum 1-6
Fructus Crataegi 1-5 Pollen Typhae 1-5 Oletum Trogopterori 2-8
Rhizoma Corydalis 1-5 1-6 Radix Ophiopogonis Fructus Schisandrae Chinensis 3-8
Massa Medicata Fermentata (parched to brown) 1-4 Fructus Amomi 2-10 Cortex Cinnamomi 1-6
Radix Astragali 3-12 Radix Paeoniae Alba 2-10 Radix Rehmanniae Preparata 1-9.
2. a kind of medicine for the treatment of pelvic venous stasis in puerperal as claimed in claim 1, it is characterized in that, described medicine comprises the raw material of following portions by weight:
Radix Angelicae Sinensis 22-28 Rhizoma Chuanxiong 5-15 Semen Persicae 2-8
Herba Leonuri 3-9 black Rhizoma Zingiberis Recens 1-6 Radix Glycyrrhizae Preparata 1-4
Cortex Moutan 3-7 black Herba Schizonepetae 1-5 Olibanum 1-6
Fructus Crataegi 1-5 Pollen Typhae 1-4 Oletum Trogopterori 2-7
Rhizoma Corydalis 1-5 1-5 Radix Ophiopogonis Fructus Schisandrae Chinensis 3-7
Massa Medicata Fermentata (parched to brown) 1-4 Fructus Amomi 2-9 Cortex Cinnamomi 1-6
Radix Astragali 3-12 Radix Paeoniae Alba 2-9 Radix Rehmanniae Preparata 1-8.
3. a kind of medicine for the treatment of pelvic venous stasis in puerperal as claimed in claim 1, it is characterized in that, described medicine comprises the raw material of following portions by weight:
Radix Angelicae Sinensis 25 Rhizoma Chuanxiong 10 Semen Persicae 6
Herba Leonuri 5 black Rhizoma Zingiberis Recens 3 Radix Glycyrrhizae Preparata 2
Cortex Moutan 5 black Herba Schizonepetae 3 Olibanum 3
Fructus Crataegi 2 Pollen Typhae 3 Oletum Trogopterori 5
Rhizoma Corydalis 3 Fructus Schisandrae Chinensis Radix Ophiopogonis 46
Massa Medicata Fermentata (parched to brown) 2 Fructus Amomi 6 Cortex Cinnamomi 3
The Radix Astragali 8 Radix Paeoniae Alba 7 Radix Rehmanniae Preparata 6.
4. a kind of preparation method for the treatment of the medicine of pelvic venous stasis in puerperal as claimed in claim 1, comprises following step:
(1) get each raw material by parts by weight described in claim 1, put into 300-500 part water and soak 20-40min;
(2) boiled for the medicine intense fire in step (1) rear slow fire is stewed 10-20min slowly, then add 20-50 part yellow wine, continue to decoct 8-15min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use;
(3) in the filtering residue of step (2), add 200-400 part water, the boiled rear slow fire of intense fire stewes 10-20min slowly, then adds 20-50 part yellow wine, continues to decoct 8-15min, Guan Huo, pours out medicinal liquid;
(4) get the medicinal liquid obtained in step (1) and (2), combine, add brown sugar 5-10 part, Stigma Croci 0.001-0.003 part, stirs, and must treat the medicine of pelvic venous stasis in puerperal.
5. a kind of preparation method for the treatment of the medicine of pelvic venous stasis in puerperal as claimed in claim 4, is characterized in that, in described step (1), put into 400 parts of water and soak half an hour.
6. a kind of preparation method for the treatment of the medicine of pelvic venous stasis in puerperal as claimed in claim 4, it is characterized in that, in described step (2), boiled for medicine intense fire in step (1) rear slow fire is stewed 15min slowly, add 40 parts of yellow wine again, continue to decoct 12min, Guan Huo, pour out medicinal liquid in container, stay filtering residue for subsequent use.
7. a kind of preparation method for the treatment of the medicine of pelvic venous stasis in puerperal as claimed in claim 4, it is characterized in that, in described step (3), 300 parts of water are added in the filtering residue of step (2), the boiled rear slow fire of intense fire stewes 15min slowly, then adds 40 parts of yellow wine, continues to decoct 12min, Guan Huo, pours out medicinal liquid.
8. a kind of preparation method for the treatment of the medicine of pelvic venous stasis in puerperal as claimed in claim 4, it is characterized in that, described brown sugar is 8 parts.
9. a kind of preparation method for the treatment of the medicine of pelvic venous stasis in puerperal as claimed in claim 4, is characterized in that, described Stigma Croci 0.002 part.
CN201510789534.1A 2015-11-17 2015-11-17 Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine Pending CN105267925A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510789534.1A CN105267925A (en) 2015-11-17 2015-11-17 Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510789534.1A CN105267925A (en) 2015-11-17 2015-11-17 Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine

Publications (1)

Publication Number Publication Date
CN105267925A true CN105267925A (en) 2016-01-27

Family

ID=55138314

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510789534.1A Pending CN105267925A (en) 2015-11-17 2015-11-17 Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine

Country Status (1)

Country Link
CN (1) CN105267925A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105664066A (en) * 2016-04-05 2016-06-15 尹克春 Medicine for treating postpartum pelvic blood stasis syndrome and preparation method thereof
CN115317587A (en) * 2022-08-30 2022-11-11 中山市中智药业集团有限公司 Composition for regulating puerperium as well as preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2150272C1 (en) * 1999-03-29 2000-06-10 Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Method for treating the cases of endometritis in cows
CN1803167A (en) * 2005-01-11 2006-07-19 南京宇道科技开发有限公司 Pharmaceutical composition mainly treating emmeniopathy and post partum disease, and its formulation and uses
CN101112596A (en) * 2007-08-29 2008-01-30 北京艺信堂医药研究所 Chinese traditional medicine composition for treating postpartum tormina
CN104940877A (en) * 2015-06-29 2015-09-30 韩志强 Sugar-free Chanfuan granules and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2150272C1 (en) * 1999-03-29 2000-06-10 Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Method for treating the cases of endometritis in cows
CN1803167A (en) * 2005-01-11 2006-07-19 南京宇道科技开发有限公司 Pharmaceutical composition mainly treating emmeniopathy and post partum disease, and its formulation and uses
CN101112596A (en) * 2007-08-29 2008-01-30 北京艺信堂医药研究所 Chinese traditional medicine composition for treating postpartum tormina
CN104940877A (en) * 2015-06-29 2015-09-30 韩志强 Sugar-free Chanfuan granules and preparation method thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
刘建平: "《当代妇科名方验方大全》", 30 April 2011, 广东科技出版社 *
姜良铎: "《乡村中医实用技术》", 30 June 2007, 中国中医药出版社 *
孙龙: "生化汤产后运用举隅", 《安徽中医临床杂志》 *
汤一新等: "《中国当代名中医秘验方临证备要》", 31 October 1993, 四川科学技术出版社 *
解发良等: "《中国古今奇效验方》", 31 March 2009, 湖南科学技术出版社 *
马大正: "《中医妇科临床药物手册》", 30 September 1992, 安徽科学技术出版社 *
黄惠卿: "《妇科证治验录》", 31 January 1982, 内蒙古人民出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105664066A (en) * 2016-04-05 2016-06-15 尹克春 Medicine for treating postpartum pelvic blood stasis syndrome and preparation method thereof
CN115317587A (en) * 2022-08-30 2022-11-11 中山市中智药业集团有限公司 Composition for regulating puerperium as well as preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN101433654B (en) Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof
CN101780160B (en) Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof
CN103638511B (en) Puerperal blood clot dispersing granule
CN105749037A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof
CN103349766B (en) Pharmaceutical composition for endless postpartum lochia
CN103393989B (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN105267925A (en) Medicine for treating postpartum pelvic blood stagnation and method for preparing medicine
CN101664525A (en) Traditional Chinese medicine for treating gynecologic diseases and preparation method thereof
Jiang et al. Effect of Chinese herbal medicine on female infertility
CN102861157A (en) Traditional Chinese medicine mixture for treating qi and blood stasis type postpartum fever
CN102772536B (en) Chinese medicine formulae for treating hepatitis with cirrhotic ascites
CN101181599B (en) Chinese medicine composition for curing chronic pelvic inflammatory disease as well as application thereof
CN103920104A (en) Traditional Chinese medicinal composition for treating uterine bleeding syndrome of puerperal coagulated phlegm in uterus
CN105233088A (en) Medicine for treating chronic pelvic inflammatory disease
CN104740582B (en) It is a kind of for the pharmaceutical preparation of puerperal blood clot dispersing and its application and detection method
CN105664066A (en) Medicine for treating postpartum pelvic blood stasis syndrome and preparation method thereof
CN104435362B (en) A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease
CN102274472A (en) Traditional Chinese medicine patch for treating female dysmenorrhoea and preparation thereof
CN104173981A (en) Medical decoction for treating uterine fibroids and hypertrophy of uterus and preparation method thereof
CN103893480A (en) Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility
CN104721799B (en) A kind of preparation process of drug particles for puerperal blood clot dispersing
CN104398972A (en) Traditional Chinese medicine treating qi-stagnation blood-stasis type hysteromyoma and preparation method
CN104984208A (en) Traditional Chinese medicine for treating menoxenia
CN106266970B (en) A kind of Chinese medicine composition treated production and cause endometritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160127

RJ01 Rejection of invention patent application after publication